Stockscreener 앱 받기
32.75
3.76%
-1.28
시간 외 거래:
33.40
0.65
+1.98%
Atricure Inc 주식(ATRC)의 최신 뉴스
Trading the Move, Not the Narrative: (ATRC) Edition - news.stocktradersdaily.com
Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Cardiac Ablation Market to Reach USD 18.7 Billion by 2034 - openPR.com
AtriCure Inc. stock trendline breakdownJuly 2025 Update & Safe Capital Allocation Plans - newser.com
How rising interest rates impact AtriCure Inc. stock2025 Market Sentiment & AI Optimized Trade Strategies - newser.com
Why AtriCure Inc. stock attracts high net worth investorsJuly 2025 Action & Target Return Focused Picks - newser.com
What’s the recovery path for long term holders of AtriCure Inc.Profit Target & Free High Return Stock Watch Alerts - newser.com
Can AtriCure Inc. stock beat market expectations this quarter2025 Macro Impact & Verified Momentum Watchlists - newser.com
AtriCure Insiders Sold US$607k Of Shares Suggesting Hesitancy - 富途牛牛
Why AtriCure Inc. stock remains undervaluedWeekly Trend Report & AI Powered Market Entry Ideas - newser.com
Is AtriCure Inc. stock near bottom after declinePortfolio Update Summary & Risk Managed Trade Strategies - newser.com
How sustainable is AtriCure Inc. stock dividend payoutJuly 2025 Summary & Free Daily Entry Point Trade Alerts - newser.com
AtriCure, Inc. $ATRC Stake Raised by Nicholas Company Inc. - MarketBeat
Is AtriCure Inc. stock overvalued by current metricsWeekly Investment Report & Precise Swing Trade Entry Alerts - newser.com
Why AtriCure Inc. stock is recommended by analysts2025 Trading Recap & Intraday High Probability Setup Alerts - newser.com
AtriCure (ATRC) Is Down 8.0% After Raising 2025 Guidance and Reporting Narrower LossesHas The Bull Case Changed? - simplywall.st
Analyzing drawdowns of AtriCure Inc. with statistical tools2025 Trading Recap & Low Risk High Reward Ideas - newser.com
Does AtriCure Inc. qualify in momentum factor screeningTrade Ideas & Real-Time Chart Breakout Alerts - newser.com
Exit strategy if you’re trapped in AtriCure Inc.Bull Run & Stepwise Swing Trade Plans - newser.com
Intraday pattern recognizer results for AtriCure Inc.Weekly Profit Analysis & Stock Portfolio Risk Management - newser.com
AtriCure, Inc. (ATRC) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
AtriCure raises 2025 revenue outlook to $532M–$534M as product launches propel double-digit growth - MSN
AtriCure, Inc. (NASDAQ:ATRC) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
AtriCure’s BoxX-NoAF Trial: A Step Forward in Cardiac Surgery Innovation - MSN
AtriCure’s Earnings Call Highlights Robust Growth and Innovation - The Globe and Mail
AtriCure, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:ATRC) 2025-10-31 - Seeking Alpha
AtriCure’s HEAL-IST IDE Trial: A Promising Step in Treating Inappropriate Sinus Tachycardia - MSN
AtriCure (NASDAQ:ATRC) Sees Large Volume Increase on Strong Earnings - MarketBeat
AtriCure (ATRC) Losses Worsen 12.8% Annually, Challenging Bullish Profitability Narratives - Sahm
Atricure (ATRC) Gets a Buy from Canaccord Genuity - The Globe and Mail
AtriCure (ATRC) Margin Miss Challenges Hopes for Near-Term Profitability Despite Strong Growth Forecasts - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Tectonic Therapeutic (TECX) and Akebia Therapeutics (AKBA) - The Globe and Mail
AtriCure Inc. stock trend forecastInsider Selling & Smart Allocation Stock Tips - newser.com
Why AtriCure Inc. stock is seen as undervaluedRate Cut & AI Optimized Trading Strategy Guides - newser.com
Canaccord Genuity raises AtriCure stock price target to $64 on strong Q3 results - Investing.com Nigeria
AtriCure stock maintains Buy rating at Needham following strong Q3 results - Investing.com Nigeria
1.48%
0.69%
자본화:
|
볼륨(24시간):